News
Brain study reveals hidden link between autism and ADHD
22+ min ago (512+ words) A study published in Molecular Psychiatry suggests that autism and ADHD may be connected at a biological level in ways that go beyond traditional diagnostic labels. While it is well known that the two conditions often occur together, the underlying…...
Accelerating Time to Data in Cell and Gene Therapy Trials, Upcoming Webinar Hosted by Xtalks
37+ min ago (169+ words) In this free webinar, gain insight into the factors impacting speed to data in CGT trials. The featured speakers will share key strategies and processes that can optimize study start-up activities and common operational bottlenecks to accelerate CGT study timelines…...
Scientists Are Engineering Plants to Glow in the Dark. They Could Soon Light Our Cities.
37+ min ago (364+ words) Although some species of fungi and more than a few animals display a variety of bioluminescent abilities, no natural plant on Earth shares such glow-in-the-dark qualities, likely due to their metabolic cost. But in a world of gene-editing tools, what…...
Fat-producing enzyme identified as key driver of damage in Parkinson's disease
58+ min ago (680+ words) News-Medical Fat-producing enzyme identified as key driver of damage in Parkinson's disease A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new target for treatment, scientists at Nanyang…...
Mysterious 'compound X' clears toxic Parkinson's proteins from brain
1+ hour, 7+ min ago (505+ words) A drug known only as compound X helped to remove the problematic proteins associated with Parkinson's disease from the brains of mice, and improved their balance and mobility Parkinson's occurs when nerve cells in the brain become depleted. This light…...
Inside Biotech: Lumonus links with top global cancer centre to sharpen AI-driven radiation planning
2+ hour, 26+ min ago (454+ words) Radiation therapy remains one of the most widely used cancer treatments, but the process of planning each patient's treatment is still complex, time-intensive and heavily dependent on specialist input. Lumonus is focused on making that process more consistent and less…...
Meet: Dr Liane dos Santos Canas
5+ hour, 49+ min ago (430+ words) By the time a disease shows symptoms, it may have been developing silently for years. Dr Liane dos Santos Canas wants to change that. As an AI+ Fellow at King's College London, she's building models that track how individual bodies…...
All Rock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
1+ hour, 34+ min ago (540+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...
Why Anti-Cancer Drugs Often Fall Short of Expectations
2+ hour, 45+ min ago (1014+ words) In the relentless pursuit of effective cancer therapies, a class of molecules known as BET inhibitors has captured significant scientific attention for over a decade. These inhibitors were heralded as a promising breakthrough due to their ability to block BET…...
GLP-1 Analysis: Riding the Wave of Peptide Innovation
1+ hour, 17+ min ago (446+ words) The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace…...